jueves, 2 de octubre de 2025

Rethinking immunotherapy in patients with SCLC with poor performance status

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00290-5/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_ers25&_hsenc=p2ANqtz-9FyjY3rZRHP9OxIaOa33b5RJypyLLe_TwZk9Os6o2I9O_YOv8LrnsCz2gPRpMk7umdwrGjB8De4cUMsrreRsVdYlrTpg&_hsmi=383112735&utm_content=383112735&utm_source=hs_email

No hay comentarios:

Publicar un comentario